Publicaciones en colaboración con investigadores/as de Hospital Universitario Doctor Peset (20)

2023

  1. Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 127

2022

  1. Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study

    Frontiers in Neurology, Vol. 13

  2. Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders

    Acta Psychiatrica Scandinavica, Vol. 146, Núm. 3, pp. 215-226

  3. Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study

    Journal of Affective Disorders, Vol. 300, pp. 99-108

2017

  1. Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study

    Journal of Affective Disorders, Vol. 215, pp. 156-162

2015

  1. Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: A difficult problem with complex solutions

    International Journal of Adolescent Medicine and Health, Vol. 27, Núm. 2, pp. 163-175

  2. Criminality and attention deficit hyperactivity disorder

    Forensic Psychiatry: A Public Health Perspective (Nova Science Publishers, Inc.), pp. 119-138

  3. Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review)

    Experimental and Therapeutic Medicine, Vol. 9, Núm. 3, pp. 643-652

2014

  1. Integrated treatment of first episode psychosis with online training (e-learning): Study protocol for a randomised controlled trial

    Trials, Vol. 15, Núm. 1

  2. Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD: The CAT Study

    Journal of Attention Disorders, Vol. 20, Núm. 12, pp. 1066-1075

  3. The role of long-acting injectable antipsychotics in schizophrenia: A critical appraisal

    Therapeutic Advances in Psychopharmacology, Vol. 4, Núm. 5, pp. 198-219

2013

  1. Attention deficit hyperactivity disorder (ADHD) In the adult patients: View of the clinician

    Actas Espanolas de Psiquiatria, Vol. 41, Núm. 3, pp. 185-195

  2. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: An individual patient data meta-analysis

    Acta Psychiatrica Scandinavica, Vol. 128, Núm. 3, pp. 149-162

  3. Understanding bipolar disorder in late life: Clinical and treatment correlates of a sample of elderly outpatients

    Journal of Nervous and Mental Disease, Vol. 201, Núm. 8, pp. 674-679

2012

  1. Clinical factors leading to lamotrigine prescription in bipolar outpatients: Subanalysis of the SIN-DEPRES study

    Journal of Affective Disorders, Vol. 143, Núm. 1-3, pp. 102-108

  2. Discapacidad en pacientes bipolares ancianos en tratamiento ambulatorio. Variables asociadas

    Revista de Psiquiatria y Salud Mental, Vol. 5, Núm. 3, pp. 183-190

  3. Pharmacological approaches in bipolar disorders and the impact on cognition: A critical overview

    Acta Psychiatrica Scandinavica, Vol. 126, Núm. 5, pp. 315-331

2011

  1. Should bipolar disorder be considered a systemic illness?

    Neuropsychiatry, Vol. 1, Núm. 1, pp. 45-54

  2. Therapeutic use of omega-3 fatty acids in bipolar disorder

    Expert Review of Neurotherapeutics, Vol. 11, Núm. 7, pp. 1029-1047

2003

  1. Specific executive/attentional deficits in patients with schizophrenia or bipolar disorder who have a positive family history of psychosis

    Journal of Psychiatric Research, Vol. 37, Núm. 6, pp. 479-486